Global Markets

Additional European Equity News

News detail

AstraZeneca (AZN LN) - AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive (immunohistochemistry [IHC] 3+) solid tumours who have received prior treatment and who have no satisfactory treatment options. (AstraZeneca) Ferrari (RACE IM) - Co. unveils Ferrari Luce, its first fully electric car, priced at EUR 550,000 including taxes. (Ferrari) Shares -5% in pre-market tradeKingfisher (KGF LN) - Q1 Trading Update (GBP): Revenue 3.30bln (exp. 3.30bln, +1.4% Y/Y), affirms Y 2026/27 guidance, sees adj. PBT between 565-625mln and FCF between 450-510mln. Confirms GBP 300mln share buyback ongoing. (Kingfisher)Nordex Group (NDX1 GY) - Co. gains new 110MW order from Eksim Enerji in Turkiye. (Nordex) Relx (REL LN) - Co. initiates GBP 150mln share buyback programme. (Relx)Ryanair (RYA ID) - Co. announces that it had repaid its only outstanding bond, leaving it effectively debt-free for the first time since the Co. was listed in 1997. (Ryanair)Saint Gobain (SGO FP) - Co. signed an agreement with Ecco Group for the sale of its Tiles Distribution business in the Nordics; no terms disclosed. (Saint Gobain)Serco (SRP LN) - Serco secures GBP 270mln contract from Norfolk and Norwich University Hospital. (Serco)   Gerresheimer (GXI GY) downgraded to Hold from Buy at JefferiesQinetiq (QQ/ LN) upgraded to Buy from Hold at Peel HuntPershing Square (PSH LN) initiated with a Hold at JefferiesRichemont (CFR SW) upgraded to Buy from Neutral at ESNTaylor Wimpey (TW/ LN) downgraded to Sell from Neutral at Goldman Sachs

7 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more